Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajesh Shinde

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Pharmaceutical Sciences|December 30, 2009
Nanoparticle formation of organic compounds with retained biological activityGunilla B Jacobson, Rajesh Shinde, Rebecca L McCullough, et al.
Indian Journal of Cancer|April 6, 2019
Bladder cancer demographics and outcome data from 2013 at a tertiary cancer hospital in IndiaGagan Prakash, Mahendra Pal, K Odaiyappan, et al.
Journal of Medicinal Chemistry|February 9, 2019
Discovery of an SSTR2-Targeting Maytansinoid Conjugate (PEN-221) with Potent Activity in Vitro and in VivoBrian H White, Kerry Whalen, Kristina Kriksciukaite, et al.
Molecular Cancer Therapeutics|October 26, 2019
Targeting the Somatostatin Receptor 2 with the Miniaturized Drug Conjugate, PEN-221: A Potent and Novel Therapeutic for the Treatment of Small Cell Lung CancerKerry A Whalen, Brian H White, James M Quinn, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Pharmaceutical Sciences|December 30, 2009
Nanoparticle formation of organic compounds with retained biological activityGunilla B Jacobson, Rajesh Shinde, Rebecca L McCullough, et al.
Indian Journal of Cancer|April 6, 2019
Bladder cancer demographics and outcome data from 2013 at a tertiary cancer hospital in IndiaGagan Prakash, Mahendra Pal, K Odaiyappan, et al.
Journal of Medicinal Chemistry|February 9, 2019
Discovery of an SSTR2-Targeting Maytansinoid Conjugate (PEN-221) with Potent Activity in Vitro and in VivoBrian H White, Kerry Whalen, Kristina Kriksciukaite, et al.
Molecular Cancer Therapeutics|October 26, 2019
Targeting the Somatostatin Receptor 2 with the Miniaturized Drug Conjugate, PEN-221: A Potent and Novel Therapeutic for the Treatment of Small Cell Lung CancerKerry A Whalen, Brian H White, James M Quinn, et al.
Pageof 2